Clinical trial of human (allogeneic) iPS cell-derived cardiomyocytes sheet for ischemic cardiomyopathy (Follow-up trial)

Phase 1

Recruiting

• Conditions: Ischemic cardiomyopathy; D017202

• Registration Number: JPRN-jRCT2053220055
• Lead Sponsor: Miyagawa Shigeru

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-22
• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

1) Patients who have undergone iPS cell derived-cardiomyocyte sheet (Clinical trial identification code:IPSOC-1) transplantation
2) Patients who can obtain concent to participate in this trial

Exclusion Criteria

none

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ifetime

Secondary Outcome Measures

Name	Time	Method
1) Number and rate of clinical events of cardiac function such as death and hospitalization<br>2) Number and rate of tumor development events